ASCO Guidelines
Podcast tekijän mukaan American Society of Clinical Oncology (ASCO)
170 Jaksot
-
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer Guideline Update
Julkaistiin: 22.1.2025 -
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer Guideline
Julkaistiin: 9.1.2025 -
Treatment of Pleural Mesothelioma Update
Julkaistiin: 8.1.2025 -
Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma Guideline
Julkaistiin: 16.12.2024 -
Systemic Therapy for SCLC Rapid Update
Julkaistiin: 20.11.2024 -
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.2
Julkaistiin: 12.11.2024 -
Management of Locally Advanced Rectal Cancer Guideline
Julkaistiin: 8.8.2024 -
Management of Stage III NSCLC Rapid Update
Julkaistiin: 23.7.2024 -
Selection of Germline Genetic Testing Panels in Patients with Cancer Guideline
Julkaistiin: 20.6.2024 -
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2024.1
Julkaistiin: 30.5.2024 -
Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards
Julkaistiin: 22.5.2024 -
Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer – CDK4/6 Inhibitors Rapid Update
Julkaistiin: 20.5.2024 -
Management of Fatigue in Adult Survivors of Cancer: ASCO-SIO Guideline Update
Julkaistiin: 16.5.2024 -
Palliative Care for Patients with Cancer Guideline Update
Julkaistiin: 15.5.2024 -
Prevention and Management of Osteoradionecrosis in Patients with Head and Neck Cancer Treated with Radiation Therapy: ISOO-MASCC-ASCO Guideline
Julkaistiin: 1.5.2024 -
Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations
Julkaistiin: 29.4.2024 -
Systemic Therapy for Advanced Hepatocellular Carcinoma Guideline Update
Julkaistiin: 19.3.2024 -
Vaccination of Adults with Cancer Guideline
Julkaistiin: 18.3.2024 -
Cannabis and Cannabinoids in Adults with Cancer Guideline
Julkaistiin: 13.3.2024 -
Endocrine and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer – Capivasertib-Fulvestrant: Rapid Guideline Update
Julkaistiin: 13.3.2024
ASCO Guidelines features key recommendations from the latest evidence-based clinical practice guidance from ASCO that you can access on the go.
